CT Simulators Market worth US$741.7 million by 2030 with 4.6% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 17, 2025 /PRNewswire/ -- The global CT Simulators Market, valued at US$569.0 million in 2024, stood at US$591.8 million in 2025 and is projected to advance at a resilient CAGR of 4.6% from 2025 to 2030, culminating in a forecasted valuation of US$741.7 million by the end of the period. The global CT simulators market is experiencing strong growth, mainly driven by the increasing worldwide incidence of cancer, which highlights the need for advanced imaging in radiation therapy planning. Growing oncology infrastructure in emerging economies such as India and China is boosting simulator installations along with rising LINAC capacity. Moreover, higher healthcare spending and supportive reimbursement policies in developed markets such as the US, the EU, and Japan are encouraging wider adoption. The increasing shift toward image-guided and adaptive radiotherapy further boosts demand for precise CT-based planning solutions.
Market leaders succeed by leveraging their established brand trust, diverse product offerings, advanced technological skills, and extensive service networks. Their strategic ecosystem alliances and deep regulatory knowledge further bolster their competitive edge, allowing them to promote adoption effectively in both developed and emerging markets.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143471038
Browse in-depth TOC on " CT Simulators Market "
300 - Tables
80 - Figures
350 - Pages
By product type, Multi-slice CT simulators dominate the market because they uniquely combine patient accommodation with large bore diameters (80–90 cm), which allow for treatment-relevant positioning and the use of immobilization devices—both essential for accurate radiotherapy planning. Multi-slice (64-slice and above) technology enables high-resolution 3D and 4D imaging, facilitating motion management in thoracic and abdominal tumors through respiratory-gated 4D CT scans. Furthermore, they are suitable for a wide range of radiotherapy techniques: IMRT, VMAT, SBRT, and proton therapy. The increasing incidence of cancer worldwide is driving demand for advanced simulation tools. Large-bore, multi-slice CT simulators are now considered the standard of care in mid- to large-sized oncology centers. They also improve workflow integration and treatment accuracy, making them indispensable for modern radiation therapy oncology. For example, the Philips Brilliance Big Bore CT Simulator is widely used in radiation oncology departments for its combination of a wide bore and multi-slice imaging, which allows for accurate tumor localization and consistent treatment setups. Additionally, Siemens SOMATOM go. Open Pro is specifically designed for radiotherapy simulation, incorporating respiratory 4D CT for motion detection management.
By technology, the 3D/4D CT simulation technology is the leading segment of the market due to the standard of care in radiation therapy. Unlike 2D simulation, 3D ensures precise dose calculation in three dimensions, making it the global standard. 3D CT simulators are widely integrated into oncology workflows, offering reliable compatibility with treatment planning systems (e.g., Varian Eclipse, Elekta Monaco, RayStation). While 4D CT enables motion management (e.g., lung and liver tumors), it is expensive and resource intensive. 3D CT offers a balance of accuracy, efficiency, and affordability, leading to broader adoption in both developed and emerging markets. Philips Brilliance Big Bore CT Simulator and Siemens SOMATOM go. Open Pro is a leading 3D CT simulator used in radiation oncology departments worldwide. They provide high-resolution volumetric images with a wide-bore design, optimized for patient positioning and treatment planning.
By geography, The US holds a significant share of the CT Simulators market for several important reasons. First, the US reports approximately 2 million new cancer cases annually (American Cancer Society, 2024), creating a strong demand for advanced simulation technologies to support radiation therapy planning. Most CT simulator OEMs have a substantial presence in the US (Siemens Healthineers, GE Healthcare, Philips, Canon Medical). Additionally, US cancer centers are early adopters of advanced imaging features such as 4D CT (respiratory motion management), dual-energy CT, and AI-driven auto-contouring tools. Substantial funding through NCI-designated cancer centers and private hospital networks drives the procurement of dedicated simulators. The U.S. Cancer Moonshot Initiative emphasizes expanding access to precision radiotherapy, indirectly boosting CT simulator demand.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=143471038
As of 2024, key players in CT Simulators market are Siemens Healthineers (Germany), GE Healthcare (US), Philips Healthcare (Netherlands), Canon Medical Systems Corporation (Japan), Varian Medical Systems (US), Elekta (Switzerland), Fujifilm Corporation (US), Fluke Biomedical (US), Ziehm Imaging Gmbh (Germany), United Imaging Healthcare (UIH) (China), Neurosoft Medical Systems (China), and Hitachi Medical Systems (Japan).
Siemens Healthineers (Germany):
Siemens Healthineers is recognized as a global leader in CT simulation, supported by its strong diagnostic imaging portfolio and oncology-focused solutions. Its flagship product is the SOMATOM go. Open Pro is a dedicated big-bore CT simulator designed with 4D imaging capabilities for motion management, respiratory gating, and smooth treatment planning integration. The big-bore design and wide field of view allow for precise patient positioning and compatibility with immobilization devices, improving accuracy in radiotherapy workflows. By leveraging its strong brand reputation in diagnostic CT and oncology imaging, along with advanced technology and an extensive service network, Siemens Healthineers is well-positioned as a preferred partner in mature healthcare systems and high-growth emerging markets.
GE Healthcare (US)
GE Healthcare is recognized as a leading player in the global CT simulators market, building on its established expertise in diagnostic imaging and oncology solutions. Its CT simulators are widely used in radiation therapy planning across North America, Europe, and key emerging markets. The company's big-bore CT simulator is specifically designed for radiation oncology, featuring an 80 cm bore, flat couch, and advanced simulation workflows. GE systems integrate seamlessly with top treatment planning platforms, including Varian Eclipse, Elekta Monaco, and RayStation. Utilizing its Revolution and Optima CT platforms, GE provides superior image quality and optimized dose management tailored for oncology. AI-powered imaging and workflow innovations further boost efficiency by reducing setup times and enhancing reproducibility. With a strong presence in the US and growing adoption in the Asia Pacific and Latin America regions, supported by hospital partnerships and government oncology initiatives, GE Healthcare continues to strengthen its position in the CT simulators market.
Elekta (Switzerland)
Elekta is a global leader in radiation therapy and oncology solutions, mainly focusing on linear accelerators (LINACs), stereotactic radiosurgery, brachytherapy, and oncology software. Unlike competitors such as Siemens, GE, and Philips, Elekta does not directly produce CT simulators. Instead, the company enters the CT simulator market through strategic partnerships and workflow integration rather than hardware manufacturing. By working with leading CT companies, including Philips, Siemens, Canon, and GE, Elekta ensures smooth interoperability of CT simulation data with its advanced treatment planning systems. This strategy helps Elekta strengthen its position in cancer care by making sure CT simulation directly improves its planning and oncology management ecosystem.
For more information, Inquire Now!
Related Reports:
Top 10 Medical Device Technologies Market
Image-Guided Radiation Therapy Market
Get access to the latest updates on CT Simulators Companies and CT Simulators Market Size
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
Share this article